Core biopsy versus FNAC for palpable breast cancers. Is image guidance necessary?

Eur J Cancer. 2003 Jan;39(1):52-6. doi: 10.1016/s0959-8049(02)00459-8.

Abstract

The aim of this study was to assess the efficacy of free-hand percutaneous core biopsy (FHCB) and to determine the role of fine needle aspiration cytology (FNAC) as diagnostic tools for palpable radiologically-suspicious breast lumps. This retrospective study was based on reviewing the clinical records of all patients diagnosed as having breast cancer between January 1999 and December 2000 and patients who had benign lesions, but suspicious breast imaging at triple assessment. Absolute sensitivity of FHCB for diagnosing cancer in palpable lesions was 98.7% compared with 51.3% for FNAC. The difference in the sensitivity of FHCB and FNAC was statistically significant (P<0.005, Wilcoxon matched pair test). Since 94.8% of radiologically-suspicious lumps were shown to be cancers, we advocate FHCB for all patients presenting with radiologically suspicious palpable lumps to our breast clinic. We also conclude that the sensitivity of FHCB for the diagnosis of malignancy in palpable radiologically-suspicious breast lesions is so high that image-guidance is unnecessary.

MeSH terms

  • Biopsy, Needle / methods*
  • Biopsy, Needle / standards
  • Breast / pathology*
  • Breast Neoplasms / pathology*
  • Carcinoma in Situ / pathology
  • Carcinoma, Ductal, Breast / pathology
  • Diagnostic Imaging
  • Female
  • Humans
  • Middle Aged
  • Retrospective Studies
  • Sensitivity and Specificity